An Experimental Drug Protects Covid-19 Patients, Eli Lilly Claims - The New York Times

An Experimental Drug Protects Covid-19 Patients, Eli Lilly Claims A so-called monoclonal antibody lowered levels of the coronavirus and prevented hospitalizations. The research has not yet been ... Read More

Eli Lilly COVID-19 antibody drug reduces hospitalizations, death risk, trial shows - Becker's Hospital Review | Healthcare News & Analysis

Eli Lilly’s COVID-19 antibody drug, bamlanivimab, significantly reduced hospitalizations and deaths due to COVID-19 in a phase 3 clinical trial. The trial, which included more than 1,000 people ... Read More

Eli Lilly antibody drug 'significantly' reduces risk of COVID-19 in nursing homes, study shows - The Week

Eli Lilly's antibody drug bamlanivimab was found to "significantly" reduce the risk of contracting symptomatic COVID-19 in nursing homes, the company has announced. "We are exceptionally pleased ... Read More

Eli Lilly's antibody drug reduces COVID-19 in nursing homes in latest study - Fox Business

Eli Lilly’s antibody drug was found to significantly reduce the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities, the company said Thursday. Read More

Eli Lilly says its COVID-19 antibody drug prevented COVID-19 in clinical trial - Becker's Hospital Review | Healthcare News & Analysis

Eli Lilly's COVID-19 antibody drug, bamlanivimab, significantly reduced the risk of contracting symptomatic COVID-19 in residents and staff of long-term care facilities, the drugmaker said Jan. 21. Read More

Eli Lilly seeks emergency use of its antibody drug for COVID-19 - New York Post

Drugmaker Eli Lilly says it has asked the US government to allow emergency use of its experimental antibody therapy based on early results from a study that suggested the drug reduced symptoms, the… ... Read More

Eli Lilly Antibody Treatment For The Coronavirus Gets FDA's OK For Emergency Use : Shots - Health News - NPR

Eli Lilly's monoclonal antibody will be available to people 65 or older or those with underlying health conditions. Supplies will be short, and allocating the medicine will be a challenge. Read More

Covid-19 Antibody Drug Shown to Reduce Hospitalizations, Eli Lilly Says - WSJ - The Wall Street Journal

An antibody-based drug derived from the blood of an early U.S. survivor of Covid-19 reduced the rate of hospitalization compared with a placebo in a new study of people recently diagnosed with the ... Read More

New coronavirus antibody treatment by Eli-Lilly reduces need for hospitalization: study - Fox Business

A clinical trial assessing Eli Lilly’s experimental antibody treatment reduced the rate of hospitalization in COVID-19 patients, the pharmaceutical company's CEO David Ricks told FOX Business ... Read More

Eli Lilly claims superiority of its weight-loss drug Zepbound after clinical trial - ConsumerAffairs

Drugmaker Eli Lilly is claiming victory in the battle of weight loss drugs, saying its Zepbound proved more effective that rival Wegovy. Eli Lilly claims superiority of its weight-loss drug ... Read More

Eli Lilly Ends Antibody Trial In Hospitalized COVID-19 Patients, Other Trials Go On : Coronavirus Updates - NPR

Eli Lilly & Co. is ending a clinical trial of its antibody drug bamlanivimab in hospitalized COVID-19 patients after federal researchers concluded the therapy produced no marked improvement. Read More